BRIEF-Biocartis and Amgen collaborate on rapid RAS biomarker testing

Wed Feb 3, 2016 1:09am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Feb 3 (Reuters) - Biocartis Group NV :

* Biocartis and Amgen collaborate to offer rapid RAS biomarker testing to selected hospitals and clinics in Brazil, Canada, Colombia, Mexico, Saudi Arabia, Spain and Turkey

* Biocartis and Amgen have entered into a collaboration to evaluate idylla RAS testing as tool for rapid decentralized testing Source text for Eikon: Further company coverage: (Gdynia Newsroom:)